IFNA1 and neoplasm: IFN has known anti-tumor activity in several types of cancer and is thought to work by stimulating natural killer cells, macrophages, and helper T cells, as well as by having direct antiproliferative effects.[26] At standard doses, IFN can be difficult to tolerate, but the low dose of IFN this patient received was tolerated without any issues.